Developing regions are focusing on tackling diabetes much more effectively
Diabetic Retinopathy Market By Type Of Treatment (Anti-Vascular Endothelial Growth Factor (VEGF) Drug, Intraocular Steroid Injection, Laser Surgery And Vitrectomy), By Indication (Non-Proliferative Diabetic Retinopathy (NPDR) (Mild, Moderate And Severe)
(EMAILWIRE.COM, August 20, 2018 ) In the year 2018, Global Diabetic Retinopathy Market was valued at USD 6.97 Billion. By the year 2023, it is predicted to reach USD 9.73 Billion with pace of 6.9% CAGR. Diabetes is a long-lasting disease which causes abnormalities in the discharge of insulin from the pancreas or hyperglycaemia related to insulin level fluctuation, which in the end prompts long haul multi-organ complexities of nerves, heart, veins, kidneys, and eyes. Diabetes eventually damages blood vessels in the retina of eyes which may result in partial or complete blindness. The treatment for these complications depends on the various stages of diabetic retinopathy.
Request Report Sample: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/request-sample
Increasing cases of diabetes and patient’s awareness towards the specific complications are expected to drive the market.
Factors affecting market growth:
• Increasing risk of blindness due to diabetes. (+)
• Increase in global geriatric population. (+)
• Early detection of diabetic retinopathy. (+)
• Increasing demand for the treatment of diabetic retinopathy. (+)
• Lack of skilled ophthalmologists. (-)
• Poor infrastructures and some strangest regulatory policies. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/customize-report
North America holds the major share of Global Diabetic Retinopathy Market
Market Segmentation
The Global Diabetic Retinopathy is geographically segmented into
• North America.
• Europe.
• Asia Pacific.
• Latin America.
• Middle East and Africa.
North America holds the major share of the market due to population of obese people and increasing demand for the treatment. Europe region is trailing right behind North America in terms of market share. In addition, Asia Pacific region is anticipated to grow quicker with greater CAGR in forecasted period owing to emerging economies such as India and China, innovation in diagnostics and funding for diabetic patients.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/
Key players:
Key players competing actively in the Global Diabetic Retinopathy Industry include Ampio Pharmaceuticals Inc., Alimera Science Inc., Abbott Laboratories Inc., Valeant Pharmaceutical International Inc., Novartis AG, Regeneron Pharmaceutical Inc., Hoffmann-La Roche ltd, Pfizer Inc., and Ayer AG.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Request Report Sample: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/request-sample
Increasing cases of diabetes and patient’s awareness towards the specific complications are expected to drive the market.
Factors affecting market growth:
• Increasing risk of blindness due to diabetes. (+)
• Increase in global geriatric population. (+)
• Early detection of diabetic retinopathy. (+)
• Increasing demand for the treatment of diabetic retinopathy. (+)
• Lack of skilled ophthalmologists. (-)
• Poor infrastructures and some strangest regulatory policies. (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/customize-report
North America holds the major share of Global Diabetic Retinopathy Market
Market Segmentation
The Global Diabetic Retinopathy is geographically segmented into
• North America.
• Europe.
• Asia Pacific.
• Latin America.
• Middle East and Africa.
North America holds the major share of the market due to population of obese people and increasing demand for the treatment. Europe region is trailing right behind North America in terms of market share. In addition, Asia Pacific region is anticipated to grow quicker with greater CAGR in forecasted period owing to emerging economies such as India and China, innovation in diagnostics and funding for diabetic patients.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/
Key players:
Key players competing actively in the Global Diabetic Retinopathy Industry include Ampio Pharmaceuticals Inc., Alimera Science Inc., Abbott Laboratories Inc., Valeant Pharmaceutical International Inc., Novartis AG, Regeneron Pharmaceutical Inc., Hoffmann-La Roche ltd, Pfizer Inc., and Ayer AG.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results